{{Rsnum
|rsid=11067228
|Chromosome=12
|position=114656455
|Orientation=plus
|GMAF=0.3618
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.9 | 46.0 | 22.1
| HCB | 24.8 | 50.4 | 24.8
| JPT | 43.4 | 46.0 | 10.6
| YRI | 83.0 | 15.6 | 1.4
| ASW | 68.4 | 24.6 | 7.0
| CHB | 24.8 | 50.4 | 24.8
| CHD | 23.9 | 54.1 | 22.0
| GIH | 25.7 | 50.5 | 23.8
| LWK | 83.6 | 15.5 | 0.9
| MEX | 37.9 | 46.6 | 15.5
| MKK | 67.9 | 27.6 | 4.5
| TSI | 36.3 | 42.2 | 21.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21160077
|Trait=None
|Title=Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
|RiskAllele=A
|Pval=2E-11
|OR=8.3000
|ORtxt=[NR] % increase
|OA=1
}}

[[Prostate-Specific Antigen]]

{{PMID Auto
|PMID=23937305
|Title=Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer
}}

{{PMID Auto
|PMID=23246478
|Title=Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}